• Patricia A Yu
  • Susan E Maslanka
  • Michael E St Louis
  • David L Swerdlow

Botulism is a neuroparalytic illness resulting from the action of a potent toxin produced by the organism Clostridium botulinum. Foodborne botulism is rare, but it may kill rapidly, and contaminated products may theoretically expose many persons to the toxin. Foodborne botulism therefore represents a medical and a public health emergency that places a premium on rapid, effective communication between clinicians and public health officials


Botulinum Toxin Cervical Dystonia Botulinum Toxin Type Botulinum Neurotoxin Mouse Bioassay 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Meyer KF, Eddie B. Fifty years of botulism in the U.S. and Canada. George Williams Hooper Foundation, University of California, San Francisco, 1950Google Scholar
  2. 2.
    McCroskey LM, Hatheway CL. Laboratory findings in four cases of adult botulism suggest colonization of the intestinal tract. J Clin Microbiol 1988;26(5):1052–4PubMedGoogle Scholar
  3. 3.
    Sonnabend O, Sonnabend W, Heinzle R, Sigrist T, Dirnhofer R, Krech U. Isolation of Clostridium botulinum type G and identification of type G botulinal toxin in humans: report of five sudden unexpected deaths. J Infect Dis 1981;143(1):22–7PubMedCrossRefGoogle Scholar
  4. 4.
    Hall JD, McCroskey LM, Pincomb BJ, Hatheway CL. Isolation of an organism resembling Clostridium baratii which produces type F botulinal toxin from an infant with botulism. J Clin Microbiol 1985;21(4):654–5PubMedGoogle Scholar
  5. 5.
    Horwitz MA, Marr JS, Merson MH, Dowell VR, Ellis JM. A continuing common-source outbreak of botulism in a family. Lancet 1975;2(7940):861–3PubMedCrossRefGoogle Scholar
  6. 6.
    Badhey H, Cleri DJ, D’Amato RF, et al. Two fatal cases of type E adult food-borne botulism with early symptoms and terminal neurologic signs. J Clin Microbiol 1986;23(3):616–8PubMedGoogle Scholar
  7. 7.
    St Louis ME, Peck SH, Bowering D, et al. Botulism from chopped garlic: delayed recognition of a major outbreak. Ann Intern Med 1988;108(3):363–8PubMedGoogle Scholar
  8. 8.
    Centers for Disease Control and Prevention, Botulism in the United States, 1899–1996: Handbook for Epidemiologists, Clinicians, and Laboratory Workers. Centers for Disease Control and Prevention, Atlanta, 1998Google Scholar
  9. 9.
    Dowell VR, Jr., McCroskey LM, Hatheway CL, Lombard GL, Hughes JM, Merson MH. Coproexamination for botulinal toxin and Clostridium botulinum. A new procedure for laboratory diagnosis of botulism. Jama 1977;238(17):1829–32PubMedCrossRefGoogle Scholar
  10. 10.
    Hatheway C, Botulism L. in: Laboratory Diagnosis of Infectious Diseases: Principles and Practice, Volume 1 (A. Balows, J. Hausler, Jr., M. Ohashi, and A. Turano, eds.), pp. 111–113, Springer-Verlag, Berlin, 1988Google Scholar
  11. 11.
    Hatheway CL, Ferreira JL. Detection and identification of Clostridium botulinum neurotoxins. Adv Exp Med Biol 1996;391:481–98PubMedGoogle Scholar
  12. 12.
    Ferreira JL, Maslanka S, Johnson E, Goodnough M. Detection of botulinal neurotoxins A, B, E, and F by amplified enzyme-linked immunosorbent assay: collaborative study. J AOAC Int 2003;86(2):314–31PubMedGoogle Scholar
  13. 13.
    Raphael BH, Andreadis JD. Real-time PCR detection of the nontoxic nonhemagglutinin gene as a rapid screening method for bacterial isolates harboring the botulinum neurotoxin (A-G) gene complex. J Microbiol Methods 2007;71(3):343–6PubMedCrossRefGoogle Scholar
  14. 14.
    Barr JR, Moura H, Boyer AE, et al. Botulinum neurotoxin detection and differentiation by mass spectrometry. Emerg Infect Dis 2005;11(10):1578–83PubMedGoogle Scholar
  15. 15.
    Leclair D, Pagotto F, Farber JM, Cadieux B, Austin JW. Comparison of DNA fingerprinting methods for use in investigation of type E botulism outbreaks in the Canadian Arctic. J Clin Microbiol 2006;44(5):1635–44PubMedCrossRefGoogle Scholar
  16. 16.
    Nevas M, Lindstrom M, Horman A, Keto-Timonen R, Korkeala H. Contamination routes of Clostridium botulinum in the honey production environment. Environ Microbiol 2006;8(6):1085–94PubMedCrossRefGoogle Scholar
  17. 17.
    Centers for Disease Control and Prevention. The Laboratory Response Network Partners in Preparedness Atlanta, GA: Centers for Disease Control and Prevention; 2005. Available at: Accessed April 2, 2008
  18. 18.
    Suen, J. C., Hatheway, C. L., Steigerwalt, A. G., et al., Clostridium argentinense, sp. nov: A genetically homogenous group composed of all strains of Clostridium botulinum toxin type G and some nontoxigenic strains previously identified asClostridium subterminale orClostridium hastiforme Int J Syst Bacteriol 1988;38: 375–82CrossRefGoogle Scholar
  19. 19.
    Ghanem FM, Ridpath AC, Moore WE, Moore LV. Identification of Clostridium botulinum, Clostridium argentinense, and related organisms by cellular fatty acid analysis. J Clin Microbiol 1991;29(6):1114–24PubMedGoogle Scholar
  20. 20.
    Cato EP, George WL, Finegold SM. Genus Clostridium, in: Bergey’s Manual of Systematic Bacteriology, Volume 2 (P. H. A. Sneath, N. S. Mair, and M. E. Sharpe, eds.), pp. 1141–1200, Williams & Wilkins, Baltimore, 1986Google Scholar
  21. 21.
    Aureli P, Fenicia L, Pasolini B, et al. Two cases of type E infant botulism caused by neurotoxigenic Clostridium butyricum in Italy. J Infect Dis 1986;154:207–11PubMedCrossRefGoogle Scholar
  22. 22.
    Smith L, Sugiyama, H. Botulism: The Organism, Its Toxins, the Disease, 2nd ed., Charles C. Thomas, Springfield, IL, 1985Google Scholar
  23. 23.
    Roberts TA, Hobbs G. Low temperature growth characteristics of clostridia. J Appl. Bacteriol 1968;31:75–88PubMedGoogle Scholar
  24. 24.
    Baird-Parker AC, Freame B. Combined effect of water activity, pH, and temperature on the growth of Clostridium botulinum from spores and vegetative cell inocula. J Appl Bacteriol 1967;30:420–9PubMedGoogle Scholar
  25. 25.
    Kim J, Foegeding PM. Principals of control, in: Clostridium botulinum: Ecology and Control in Foods (A. H. W. Hauschild and K. L. Dodds, eds.), pp. 121–176, Marcel Dekker, New York, 1992Google Scholar
  26. 26.
    Ito KA, Seslar DJ, Ercern WA, et al. The thermal and chlorine resistance of Clostridium botulinum types A, B, and E spores, in: Botulism 1966 (M. Ingram and T. A. Roberts, eds.), pp. 108–122, Chapman & Hall, London, 1967Google Scholar
  27. 27.
    Roberts TA, Ingram M. The resistance of spores of Clostridium botulinum type E to heat and radiation. J Appl Bacteriol 1965;28:125–37Google Scholar
  28. 28.
    Zezones H, Hutchings IJ. Thermal resistance of Clostridium botulinum (62A) spores as affected by fundamental food constituents. Food Technol 1965;19:1003–5Google Scholar
  29. 29.
    El Bisi HM. Radiation death kinetics of C. botulinum spores at cryogenic temperatures, in: Botulism 1966 (M. Ingram and T. A. Roberts, eds.), pp. 89–107, Chapman & Hall, London, 1967Google Scholar
  30. 30.
    Pivnick H, Johnston MA, Thacker C, et al. Effect of nitrite on destruction and germination of Clostridium botulinum and putrefactive anaerobes 3679 and 3679 h in meat and in buffer. Can Inst Food Technol J 1970;3:103–9Google Scholar
  31. 31.
    Eklund MW, Poysky FT, Reed SM et al. Bacteriophage and the toxigenicity ofClostridium botulinum type C. Science 1971;172: 480–2PubMedCrossRefGoogle Scholar
  32. 32.
    Eisel V, Jarausch W, Goretsky K, et al. Tetanus toxin: Primary structure, expression in E. coli, and homology with botulinum toxins. EMBO J 1986;5:2495–502PubMedGoogle Scholar
  33. 33.
    Marshall KM, Bradshaw M, Pellett S, Johnson EA. Plasmid encoded neurotoxin genes in Clostridium botulinum serotype A subtypes. Biochem Biophys Res Commun 2007;361(1):49–54PubMedCrossRefGoogle Scholar
  34. 34.
    Mitsui N, Kiritani K, Nishida S. A lysin(s) in lysates of Clostridium botulinum A190 induced by ultra-violet ray or mitomycin C. Jpn J Microbiol 1973;17:353–60PubMedGoogle Scholar
  35. 35.
    Roblot R, Fauchere JL, Devilleger A, et al. Retrospective study of 108 cases of botulism in Poiters, France. J Med Microbiol 1994;40: 379–84PubMedCrossRefGoogle Scholar
  36. 36.
    Hauschild AHW, Gauvreau L. Food-borne botulism in Canada, 1971–1984. Can Med Assoc J 1985;133:1141–6Google Scholar
  37. 37.
    Iida H. Epidemiological and clinical observations of botulism outbreaks in Japan, in: Proceedings of the First U.S.—Japan Conference on Toxic Microorganisms (M. Herzberg, ed.), pp. 357–359, US Department of the Interior, Washington, DC, 1970Google Scholar
  38. 38.
    Dawar M, Moody L, Martin JD, Fung C, Isaac-Renton J, Patrick DM. Two outbreaks of botulism associated with fermented salmon roe—British Columbia, August 2001. Can Commun Dis Rep 2002;28(6):45–9PubMedGoogle Scholar
  39. 39.
    Shih Y, Chao S. Botulism in China. Rev Infect Dis 1986;8:984–90PubMedCrossRefGoogle Scholar
  40. 40.
    Woodruff BA, Griffin PM, McCroskey LM, et al. Clinical and laboratory comparison of botulism from toxin types A, B, and E in the United States, 1975–1988. J Infect Dis 1992;166:1281–6PubMedCrossRefGoogle Scholar
  41. 41.
    Weber JT, Hibbs RG, Darwish A, et al. A massive outbreak of type E botulism associated with traditional salted fish in Cairo. J Infect Dis 1993;167:451–4PubMedCrossRefGoogle Scholar
  42. 42.
    Varma JK, Katsitadze G, Moiscrafishvili M, et al. Foodborne botulism in the Republic of Georgia. Emerg Infect Dis 2004;10(9): 1601–5PubMedGoogle Scholar
  43. 43.
    Lindstrom M, Vuorela M, Hinderink K, et al. Botulism associated with vaccum-packed smoked whitefish in Finland, June–July 2006. Euro Surveill 2006;11(7):E060720 3PubMedGoogle Scholar
  44. 44.
    Korkeala H, Stengel G, Hyytia E, et al. Type E botulism associated with vaccum-packaged hot-smoked whitefish. Int J Food Microbiol 1998;43(1–2):1–5PubMedCrossRefGoogle Scholar
  45. 45.
    Kongsaengdao S, Samintarapanya K, Rusmeechan S, et al. An outbreak of botulism in Thailand: clinical manifestations and management of severe respiratory failure. Clin Infect Dis 2006;43(10): 1247–56PubMedCrossRefGoogle Scholar
  46. 46.
    Swaddiwudhipong W, Wongwatcharapaiboon P. Foodborne botulism outbreaks following consumption of home-canned bamboo shoots in Northern Thailand. J Med Assoc Thai 2000;83(9):1021–5PubMedGoogle Scholar
  47. 47.
    Meusburger S, Reichert S, Heibl S, et al. Outbreak of foodborne botulism linked to barbecue, Austria, 2006. Euro Surveill 2006; 11(12):E061214 4PubMedGoogle Scholar
  48. 48.
    Cengiz M, Yilmaz M, Dosemeci L, Ramazanoglu A. A botulism outbreak from roasted canned mushrooms. Hum Exp Toxicol 2006;25(5):273–8PubMedCrossRefGoogle Scholar
  49. 49.
    Frean J, Arntzen L, van den Heever J, Perovic O. Fatal type A botulism in South Africa, 2002. Trans R Soc Trop Med Hyg 2004; 98(5):290–5PubMedCrossRefGoogle Scholar
  50. 50.
    Aureli P, Di Cunto M, Maffei A, et al. An outbreak in Italy of botulism associated with a dessert made with mascarpone cream cheese. Eur J Epidemiol 2000;16(10):913–8PubMedCrossRefGoogle Scholar
  51. 51.
    Flacks L. Botulism in New Zealand. N Z Med J 1985;98(789):892–3PubMedGoogle Scholar
  52. 52.
    Whyte R, Hudson JA, Hasell S, Gray M, O’Reilly R. Traditional Maori food preparation methods and food safety. Int J Food Microbiol 2001;69(3):183–90PubMedCrossRefGoogle Scholar
  53. 53.
    Yu PA, Maslanka SE, Barzilay EJ, Sobel J, Swerdlow DL. Botulism in the United States, 1997–2006 [Abstract]. Presented at the meeting of the International Conference on Emerging Infectious Diseases (ICEID); March 16–19, 2008; Atlanta, GAGoogle Scholar
  54. 54.
    Mann JM, Hatheway CL, Gardiner TM. Laboratory diagnosis in a large outbreak of type A botulism. Confirmation of the value of coproexamination. Am J Epidemiol 1982;115:598–605PubMedGoogle Scholar
  55. 55.
    Seals JE, Snyder JD, Edell TA, et al. Restaurant-associated type A botulism: Transmission by potato salad. Am J Epidemiol 1981;113: 436–44PubMedGoogle Scholar
  56. 56.
    Centers for Disease Control, Botulism from fresh foods—California. Morbid Mortal Week Rep 1985;34:156–7Google Scholar
  57. 57.
    Angulo FJ, Getz J, Taylor JP, et al. A large outbreak of botulism: the hazardous baked potato. J Infect Dis 1998;178(1):172–7PubMedGoogle Scholar
  58. 58.
    MacDonald KL, Spengler RF, Hatheway CL, et al. Type A botulism from sauteed onions. J Am Med Assoc 1985; 253: 1275–8CrossRefGoogle Scholar
  59. 59.
    California Department of Health Services, Type A botulism associated with commercial pot pie, California Morbidity, December 30, 1976, p. 51Google Scholar
  60. 60.
    Centers for Disease Control and Prevention. Botulism Atlanta, GA: Centers for Disease Control and Prevention. Available at: Accessed April 2, 2008
  61. 61.
    Hashimoto H, Clyde VJ, Parko KL. Botulism from peyote. N Engl J Med 1998;339(3):203–4Google Scholar
  62. 62.
    Centers for Disease Control and Prevention. Brief Report: Foodborne Botulism from Home-Prepared Fermented Tofu—California, 2006. Morbid Mortal Week Rep 2007;56:96–97Google Scholar
  63. 63.
    Sobel J, Tucker N, Sulka A, McLaughlin J, Maslanka S. Foodborne botulism in the United States, 1990–2000. Emerg Infect Dis 2004;10(9):1606–11PubMedGoogle Scholar
  64. 64.
    Kalluri P, Crowe C, Reller M, et al. An outbreak of foodborne botulism associated with food sold at a salvage store in Texas. Clin Infect Dis 2003;37(11):1490–5PubMedCrossRefGoogle Scholar
  65. 65.
    Botulism associated with commercial carrot juice—Georgia and Florida, September 2006. MMWR Morb Mortal Wkly Rep 2006; 55(40):1098–9Google Scholar
  66. 66.
    Botulism Associated with Commercially Canned Chili Sauce—Texas and Indiana, July 2007. MMWR Morb Mortal Wkly Rep 2007;56(Dispatch):1–3Google Scholar
  67. 67.
    MacDonald KL, Cohen ML, Blake PA. The changing epidemiology of adult botulism in the United States. Am J Epidemiol 1986;124:794–9PubMedGoogle Scholar
  68. 68.
    Mann JM, Lathrop GD, Bannerman JA. Economic impact of a botulism outbreak. Importance of the legal component in food-borne disease. J Am Med Assoc 1983;249:1299–301CrossRefGoogle Scholar
  69. 69.
    Mann JM, Martin S, Hoffman RE, et al. Patient recovery from type A botulism: Morbidity assessment following a large outbreak. Am J Public Health 1981;71:266–9PubMedCrossRefGoogle Scholar
  70. 70.
    Schmidt-Nowara WW, Samet JM, Rosario PA. Early and late pulmonary complications of botulism. Arch Intern Med 1983;143(3): 451–6PubMedCrossRefGoogle Scholar
  71. 71.
    Cherington M. Botulism: Ten-year experience. Arch Neurol 1974;30: 432–7PubMedGoogle Scholar
  72. 72.
    Gottlieb SL, Kretsinger K, Tarkhashvili N, et al. Long-term outcomes of 217 botulism cases in the Republic of Georgia. Clin Infect Dis 2007;45(2):174–80PubMedCrossRefGoogle Scholar
  73. 73.
    Cohen FL, Hardin SB, Nehring W, et al. Physical and psychosocial health status 3 years after catastrophic illness—botulism. Issues Ment Health Nurs 1988;9(4):387–98PubMedCrossRefGoogle Scholar
  74. 74.
    Wilcox P, Andolfatto G, Fairbarn MS, Pardy RL. Long-term follow-up of symptoms, pulmonary function, respiratory muscle strength, and exercise performance after botulism. Am Rev Respir Dis 1989;139(1):157–63PubMedGoogle Scholar
  75. 75.
    Gangarosa EJ, Donadio JA, Armstrong RW, et al. Botulism in the United States, 1899–1969. Am J Epidemiol 1971;93:91–100Google Scholar
  76. 76.
    Horwitz MA, Hughes JM, Merson MH, et al. Foodborne botulism in the United States, 1970–1975. J Infect Dis 1977;136:153–9PubMedCrossRefGoogle Scholar
  77. 77.
    Hughes JM, Blumenthal JR, Merson MH, et al. Clinical features of types A and B food-borne botulism. Ann Intern Med 1981;95: 442–5PubMedGoogle Scholar
  78. 78.
    Smith LD. The occurrence of Clostridium botulinum and Clostridium tetani in the soil of the United States. Health Lab Sci 1978;15: 74–80PubMedGoogle Scholar
  79. 79.
    Wainwright RB, Heyward WL, Middaugh JP, et al. Foodborne botulism in Alaska, 1947–1985: Epidemiology and clinical findings. J Infect Dis 1988;157:1158–62 (1988)PubMedCrossRefGoogle Scholar
  80. 80.
    Arnon SS. Infant botulism, in: Textbook of Pediatric Infectious Diseases (R. Feigen and J. Cherry, eds.), pp. 1095–1102, W.B. Saunders, Philadelphia, 1992Google Scholar
  81. 81.
    Midura TF, Arnon SS. Infant botulism: Identification of Clostridium botulinum and its toxin in faeces. Lancet 1976;2:934–6PubMedCrossRefGoogle Scholar
  82. 82.
    Pickett J, Berg B, Chaplin E, et al. Syndrome of botulism in infancy. N Engl J Med 1976;295:770–2PubMedCrossRefGoogle Scholar
  83. 83.
    Dodds KL. Worldwide incidence and ecology of infant botulism, in: Clostridium botulinum: Ecology and Control in Foods (A. H. W. Hauschild and K. L. Dodds, eds.), pp. 105–107, Marcel Dekker, New York, 1993Google Scholar
  84. 84.
    Hatheway CL, McCroskey LM. Examination of feces and serum for diagnosis of infant botulism in 336 patients. J Clin Microbiol 1987;25:2334–8PubMedGoogle Scholar
  85. 85.
    Barash JR, Arnon SS. Dual toxin-producing strain of Clostridium botulinum type Bf isolated from a California patient with infant botulism. J Clin Microbiol 2004;42(4):1713–5PubMedCrossRefGoogle Scholar
  86. 86.
    Hatheway CL, McCroskey LM. Examination of feces and serum for diagnosis of infant botulism in 336 patients. J Clin Microbiol 1987;25(12):2334–8PubMedGoogle Scholar
  87. 87.
    Long SS, Gajewski JL, Brown LW, et al. Clinical, laboratory, and environmental features of infant botulism in southeastern Pennsylvania. Pediatrics 1985;75:935–41Google Scholar
  88. 88.
    Morris JG., Snyder JD, Wilson R, et al. Infant botulism in the United States: An epidemiologic study of the cases occurring outside California. Am J Public Health 1985;73:1385–8PubMedCrossRefGoogle Scholar
  89. 89.
    Istre GR, Compton R, Novotny T, et al. Infant botulism: Three cases in a small town. Am J Dis Child 1986;140:1013–4PubMedGoogle Scholar
  90. 90.
    Long SS. Epidemiologic study of infant botulism in Pennsylvania. Pediatrics 1985;75:928–34PubMedGoogle Scholar
  91. 91.
    Thompson JA, Glasgow LA, Warpinski JR. Infant botulism: Clinical spectrum and epidemiology. Pediatrics 1980;66:936–42PubMedGoogle Scholar
  92. 92.
    Nevas M, Lindstrom M, Virtanen A, et al. Infant botulism acquired from household dust presenting as sudden infant death syndrome. J Clin Microbiol 2005;43(1):511–3PubMedCrossRefGoogle Scholar
  93. 93.
    Arnon SS, Midura TF, Damus K, et al. Intestinal infection and toxin production by Clostridium botulinum as one cause of sudden infant death syndrome. Lancet 1978;1:1273–7PubMedCrossRefGoogle Scholar
  94. 94.
    Sonnabend OA, Sonnabend WF, Krech U, Molz G, Sigrist T. Continuous microbiological and pathological study of 70 sudden and unexpected infant deaths: toxigenic intestinal clostridium botulinum infection in 9 cases of sudden infant death syndrome. Lancet 1985;325(8423):237–41CrossRefGoogle Scholar
  95. 95.
    Aureli P, Ferrini AM. Identification of C. botulinum spores in a case of sudden infant death in Italy. Description of a clinical case. Minerva Pediatr 1988;40(2):125–6Google Scholar
  96. 96.
    Bohnel H, Behrens S, Loch P, Lube K, Gessler F. Is there a link between infant botulism and sudden infant death? Bacteriological results obtained in central Germany. Eur J Pediatr 2001;160(10): 623–8Google Scholar
  97. 97.
    Peterson DR, Eklund MW, Chinn NM. The sudden infant death syndrome and infant botulism. Rev Infect Dis 1979;1(4):630–6Google Scholar
  98. 98.
    Murrell WG, Stewart BJ, O’Neill C, Siarakas S, Kariks S. Enterotoxigenic bacteria in the sudden infant death syndrome. J Med Microbiol 1993;39(2):114–27Google Scholar
  99. 99.
    Weber JT, Goodpasture HC, Alexander H, et al. Wound botulism in a patient with a tooth abscess: Case report and review. Clin Infect Dis 1993;16:635–9PubMedCrossRefGoogle Scholar
  100. 100.
    Merson MH, Dowell VR. Epidemiologic, clinical, and laboratory aspects of wound botulism. N Engl J Med 1973;289:1005–10PubMedCrossRefGoogle Scholar
  101. 101.
    Wound botulism associated with parenteral cocaine abuse—New York City. MMWR Morb Mortal Wkly Rep 1982;31(7): 87–8Google Scholar
  102. 102.
    MacDonald KL, Rutherford GW, Friedman SM, et al. Botulism and botulism-like illness in chronic drug abusers. Ann Intern Med 1985;102:616–8PubMedGoogle Scholar
  103. 103.
    Passaro DJ, Werner SB, McGee J, Mac Kenzie WR, Vugia DJ. Wound botulism associated with black tar heroin among injecting drug users. Jama 1998;279(11):859–63PubMedCrossRefGoogle Scholar
  104. 104.
    Werner SB, Passaro D, McGee J, Schechter R, Vugia DJ. Wound botulism in California, 1951–1998: recent epidemic in heroin injectors. Clin Infect Dis 2000;31(4):1018–24PubMedCrossRefGoogle Scholar
  105. 105.
    Akbulut D, Dennis J, Gent M, et al. Wound botulism in injectors of drugs: upsurge in cases in England during 2004. Euro Surveill 2005;10(9):172–4PubMedGoogle Scholar
  106. 106.
    Galldiks N, Nolden-Hoverath S, Kosinski CM, et al. Rapid geographical clustering of wound botulism in Germany after subcutaneous and intramuscular injection of heroin. Neurocrit Care 2007;6(1):30–4PubMedCrossRefGoogle Scholar
  107. 107.
    Chia JK, Clark JB, Ryan CA, et al. Botulism in an adult associated with foodborne intestinal infection with Clostridium botulinum. N Engl J Med 1986;315:239–41PubMedCrossRefGoogle Scholar
  108. 108.
    Chertow DS, Tan ET, Maslanka SE, et al. Botulism in 4 adults following cosmetic injections with an unlicensed, highly concentrated botulinum preparation. Jama 2006;296(20):2476–9PubMedCrossRefGoogle Scholar
  109. 109.
    Souayah N, Karim H, Kamin SS, McArdle J, Marcus S. Severe botulism after focal injection of botulinum toxin. Neurology 2006;67(10):1855–6PubMedCrossRefGoogle Scholar
  110. 110.
    Crowner BE, Brunstrom JE, Racette BA. Iatrogenic botulism due to therapeutic botulinum toxin a injection in a pediatric patient. Clin Neuropharmacol 2007;30(5):310–3PubMedCrossRefGoogle Scholar
  111. 111.
    Cote TR, Mohan AK, Polder JA, Walton MK, Braun MM. Botulinum toxin type A injections: adverse events reported to the US Food and Drug Administration in therapeutic and cosmetic cases. J Am Acad Dermatol 2005;53(3):407–15PubMedCrossRefGoogle Scholar
  112. 112.
    Health and Welfare Canada, Restaurant-associated botulism from in-house bottled mushrooms—British Columbia. Can Dis Week Rep 1987;13:35–6Google Scholar
  113. 113.
    United States Department of Agriculture, Home Canning of Fruits and Vegetables, Home and Garden Bulletin, No. 8, USDA, Washington, DC, 1975Google Scholar
  114. 114.
    Shaffer N, Wainwright RB, Middaugh JP. Botulism among Alaska natives: The role of changing food preparation and consumption practices. West J Med 1990;153:390–3PubMedGoogle Scholar
  115. 115.
    Kautter DA, Lilly T, Solomon HM, et al. Clostridium botulinum spores in infant foods: A survey. J Food Protect 1982;45:1028–9Google Scholar
  116. 116.
    Arnon SS, Midura TF, Damus K. Honey and other environmental risk factors for infant botulism. J Pediatr 1979;94:331–6PubMedCrossRefGoogle Scholar
  117. 117.
    Chin J, Arnon SS, Midura TF. Food and environmental aspects of infant botulism in California. Rev Infect Dis 1979;1:693–6PubMedCrossRefGoogle Scholar
  118. 118.
    Spika JS, Shaffer N, Hargrett-Bean N. Risk factors for infant botulism in the United States. Am J Dis Child 1989;143:828–32PubMedGoogle Scholar
  119. 119.
    Arnon SS, Damus K, Thompson B, et al. Protective role of human milk against sudden death from infant botulism. J Pediatr 1982;10:568–73Google Scholar
  120. 120.
    Wilson R, Morris JG, Snyder JD, et al. Clinical characteristics of infant botulism in the United States: A study of the non-California cases. Pediatr Infect Dis 1982;1:148–50PubMedCrossRefGoogle Scholar
  121. 121.
    Wells CL, Sugiyama H, Bland SE. Resistance of mice with limited intestinal flora to enteric colonization by Clostridium botulinum J Infect Dis 1982;146:791–6PubMedCrossRefGoogle Scholar
  122. 122.
    Centers for Disease Control, Botulism—Kentucky. Morbid Mortal Week Rep 1973;22:417Google Scholar
  123. 123.
    Tacket CO, Shandera WX, Mann JM, Hargrett NT, Black PA. Equine antitoxin use and other factors that predict outcome in type A foodborne botulism. Am J Med 1984;76:794–8PubMedCrossRefGoogle Scholar
  124. 124.
    Simpson LL. Identification of the major steps in botulinum toxin action. Annu Rev Pharmacol Toxicol 2004;44:167–93Google Scholar
  125. 125.
    Kao I, Drachman DB, Price DL. Botulism toxin: Mechanism of presynaptic blockade. Science 1976;193:1245–58CrossRefGoogle Scholar
  126. 126.
    Sugiyama H. Clostridium botulinum neurotoxin. Microbiol Rev 1980;44:419–48PubMedGoogle Scholar
  127. 127.
    Sellin LC, Thesleff S, Dasgupta BR. Different effects of types A and B botulinum toxin on transmitter release at the rat neuromuscular junction. Acta Physiol Scand 1983;119:127–33PubMedCrossRefGoogle Scholar
  128. 128.
    Griffin PM, Hatheway CL, Rosenbaum RB, Sokolow R. Endogenous antibody production to botulinum toxin in an adult with intestinal colonization botulism and underlying Crohn’s disease. J Infect Dis 1997;175(3):633–7PubMedCrossRefGoogle Scholar
  129. 129.
    Sugiyama H, Mills DC. Intraintestinal toxin in infant mice challenged with Clostridium botulinum spores. Infect Immun 1978;21:59–63PubMedGoogle Scholar
  130. 130.
    Moberg LJ, Sugiyama H. Microbial ecological basis of infant botulism as studied with germfree mice. Infect Immunol 1979;25: 653–7Google Scholar
  131. 131.
    Burr DH, Sugiyama H. Susceptibility to enteric botulinum colonization of antibiotic-treated adult mice. Infect Immun 1982;36:103–6PubMedGoogle Scholar
  132. 132.
    Ungchusak K, Chunsuttiwat S, Braden C, et al. The need for global planned mobilization of essential medicine: lessons from a massive Thai botulism outbreak. Bull World Health Organ 2007;85(3): 238–40Google Scholar
  133. 133.
    L’Hommedieu C, Stough R, Brown L. Potentiation of neuromuscular weakness in infant botulism by aminoglycosides. J Pediatr 1979;95:1065–70PubMedCrossRefGoogle Scholar
  134. 134.
    Arnon SS, Schechter R, Maslanka SE, Jewell NP, Hatheway CL. Human botulism immune globulin for the treatment of infant botulism. N Engl J Med 2006;354(5):462–71PubMedCrossRefGoogle Scholar
  135. 135.
    Koenig GM, Spickard A, Cardella MA, et al. Clinical and laboratory observations on type B botulism in man. Medicine 1964;43:517–45PubMedCrossRefGoogle Scholar
  136. 136.
    Terranova WA, Palumbo JN, Breman JG. Ocular findings in botulism type B. J Am Med Assoc 1979;241:475–7CrossRefGoogle Scholar
  137. 137.
    Cherington M, Ginsberg S. Type B botulism: Neurophysiologic studies. Neurology 1971;21:43–6PubMedGoogle Scholar
  138. 138.
    Kimura J. Electrodiagnosis in Diseases of Nerve and Muscle, Davis, Philadelphia, 1983Google Scholar
  139. 139.
    Clay SA, Ramseyer JD, Fishjman LS, et al. Acute infantile motor unit disorder: Infant botulism. Arch Neurol 1977;34:236–43PubMedGoogle Scholar
  140. 140.
    Cornblath DR, Sladsky JT, Sumner AJ. Clinical electrophysiology of infantile botulism. Muscle Nerve 1983;6:448–52PubMedCrossRefGoogle Scholar
  141. 141.
    Engel WK. Brief, small, abundant motor unit potentials. Neurology 1975;25:173–6PubMedGoogle Scholar
  142. 142.
    Centers for Disease Control, Follow-up: Botulism associated with commercial cherry peppers. Morbid Mortal Week Rep 1976;25:148Google Scholar
  143. 143.
    Terranova WA, Breman JG, Locey RP, et al. Botulism type B: Epidemiologic aspects of an extensive outbreak. Am J Epidemiol 1978;108:150–6PubMedGoogle Scholar
  144. 144.
    Morse DL, Pickard LK, Guzewich JJ, et al. Garlic-in-oil associated botulism: Episode leads to product modification. Am J Public Health 1990;80:1372–4PubMedCrossRefGoogle Scholar
  145. 145.
    Cardella MA. Botulinum toxoids, in: Botulism (K. H. Lewis and K. Cassel, eds.), pp. 113–130, US Public Health Service, Cincinati, 1964Google Scholar
  146. 146.
    Chang GY, Ganguly G. Early antitoxin treatment in wound botulism results in better outcome. Eur Neurol 2003;49(3):151–3PubMedCrossRefGoogle Scholar
  147. 147.
    Hatheway CL, Snyder JD, Seals JD, et al. Antitoxin levels in botulism patients treated with trivalent equine botulism antitoxin to toxin types A, B, and E. J Infect Dis 1984;150:407–12PubMedCrossRefGoogle Scholar
  148. 148.
    Black RE, Gunn RA. Hypersensitivity reactions associated with botulinal antitoxin. Am J Med 1980;69:567–70PubMedCrossRefGoogle Scholar
  149. 149.
    Underwood K, Rubin S, Deakers T, Newth C. Infant botulism: a 30-year experience spanning the introduction of botulism immune globulin intravenous in the intensive care unit at Childrens Hospital Los Angeles. Pediatrics 2007;120(6):e1380–5PubMedCrossRefGoogle Scholar
  150. 150.
    Biological and Chemical Terrorism: Strategic Plan for Preparedness and Response. MMWR Morb Mortal Wkly Rep 2000;49(RR04): 1–14Google Scholar
  151. 151.
    Arnon SS, Schechter R, Inglesby TV, et al. Botulinum toxin as a biological weapon: medical and public health management. Jama 2001;285(8):1059–70PubMedCrossRefGoogle Scholar
  152. 152.
    Middlebrook JL, Franz Dr. Botulinum Toxins. In: Zajtchuk R, Bellamy RF, eds. Medical Aspects of Chemical and Biological Warfare. pp. 643–654, Office of the Surgeon General, Washington, DC, 1997Google Scholar
  153. 153.
    Horowitz BZ. Botulinum toxin. Crit Care Clin 2005;21(4): 825–39, viiiPubMedCrossRefGoogle Scholar

Suggested Reading

  1. Arnon SS. Infant botulism, in: Textbook of Pediatric Infectious Diseases (R. Feigen and J. Cherry, eds.), pp. 1095–1102, W. B. Saunders, Philadelphia, 1992Google Scholar
  2. Centers for Disease Control and Prevention, Botulism in the United States, 1899–1996: Handbook for Epidemiologists, Clinicians, and Laboratory Workers, Centers for Disease Control and Prevention, Atlanta, 1998Google Scholar
  3. Hatheway C, Botulism L, in: Laboratory Diagnosis of Infectious Diseases: Principles and Practice, Volume 1 (A. Balows, J. Hausler, Jr., M. Ohashi, and A. Turano, eds.), pp. 111–113, Springer-Verlag, Berlin, 1988Google Scholar
  4. Weber JT, Goodpasture HC, Alexander H, et al. Wound botulism in a patient with a tooth abscess: Case report and review. Clin Infect Dis 1993; 16:635–9PubMedCrossRefGoogle Scholar
  5. Hatheway CL. Toxigenic clostridia. Clin Microbiol Rev 3:66–98Google Scholar
  6. State of Alaska Department of Health and Social Services, Botulism in Alaska: A Guide for Physicians and Health Care Providers, Alaska Printing, Anchorage, 1994Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • Patricia A Yu
    • 1
  • Susan E Maslanka
    • 2
  • Michael E St Louis
    • 3
  • David L Swerdlow
  1. 1.Strategic Science and Program UnitCoordinating Center for Infectious Diseases, Centers for Disease Control and PreventionAtlantaUSA
  2. 2.National Botulism Surveillance and Reference LaboratoryCenters for Disease Control and PreventionAtlantaUSA
  3. 3.Division of STD Prevention, National Center for HIV, STD, and TB PreventionCenters for Disease Control and PreventionAtlantaUSA

Personalised recommendations